A record-breaking year for NYC startup funding capped off with a near record-breaking $4B raised in December; just shy of July’s $4.1B high!
Today, I take a look at the state of venture capital and early-stage funding for December 2021 in New York. Analyzing some publicly available data from our friends at CrunchBase, we break down the aggregate statistics for all funding deals by stage of funding (Early-stage [Pre-Seed, Seed], Series A, Series B, and Late Stage [Series C+]) including mention of notable rounds. In order to maintain a focus on tech-enabled startups, this analysis does not include rounds for biotech, real estate, lending startups as well as debt financings.
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
The average Seed round in NYC for December was $3.9M Tweet This
The median Seed round in NYC for December was $3.1M Tweet This
$169.6M was invested across early stages rounds in NYC in December Tweet This
20% of early-stage funding nationally went to startups in NYC in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on.
Get in on this rapidly growing startup and learn how you can invest today
The average Series A round in NYC for December was $14.0M Tweet This
The median Series A round in NYC for December was $11.0M Tweet This
$237.7M was invested across Series A rounds in NYC in December Tweet This
9% of Series A funding nationally went to startups in NYC in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
The average Series B round in NYC for December was $36.1M Tweet This
The median Series B round in NYC for December was $25.0M Tweet This
$939.9M was invested across Series B rounds in NYC in December Tweet This
21% of Series B funding nationally went to startups in NYC in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on.
Get in on this rapidly growing startup and learn how you can invest today
The average late-stage round in NYC for December was $149.7M Tweet This
The median late-stage round in NYC for December was $60.5M Tweet This
$2.7B was invested across late-stage rounds in NYC in December Tweet This
27% of late-stage funding nationally went to startups in NYC in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
$4.0B was invested in NYC #startups in December in NYC across 105 deals Tweet This
22% of startup funding nationally went to startups in NYC in December Tweet This
NYC VC funding in December was +22% from last month and +153% from the same period last year Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on.